top of page

Search Results

34 items found for ""

  • HemChip | Hememics

    He m Chi p ® Small, Portable, & Disposable Biosensor HemChip The Hem Chip ® is made with a bior eceptor layer and a proprietary biochip, designed to detect pathogens with utmost speed, accuracy, and sensitivity. ® Back ​ ​ Each Hem Chip ® contains multiple biosensors, enabling the detection of multiple pathogens simultaneously. The Hem Box and Hem Chip ® work in tandem ,with the Hem Box interpreting the signals that the Hem Chip ® outputs, giving the user their real-time results in less than 5 minutes. TM TM ® < Previous Next > QUOTE

  • Career | Hememics

    Unlock Your Potential with Us Ready to take your career to new heights? At Hememics, we're committed to fostering your growth and development, providing a dynamic environment where you can excel and achieve your professional goals. Full-time/ Internship Apply Now Open Positions We're excited to open diverse opportunities within our organization. While a connection to biotechnology is beneficial, we believe that any candidate that showcases the skills and qualities aligned with our values would succeed with us. Hememics thrives on innovation, dedication, and excellence, and whether you'r experienced or not, we invite you to join us in shaping a dynamic industry. Your potential is the driving force behind our development, and we look forward to the contributions you can bring to our team. What We Expect Intellectual Agility We're on the lookout for individuals with smart, agile minds. Your ability to grasp complex concepts swiftly, connect diverse ideas, and synthesize information into meaningful insights is highly valued here. What You Get in Return Professional Growth Joining us means embarking on a journey of continuous learning and development. You'll have access to resources, workshops, and mentorship that will nurture your skills and help you reach new heights in your career. Internship If you have an interest in joining our team but lack experience in your field, we're happy to help you in taking those initial steps. Apply Now

  • Mary E. Schmidt, MD | Hememics

    Go back Mary E. Schmidt, MD Board member President, Schmidt & Libby Health Advisory Group Associate Professor of Clinical Medicine, VCU Dr. Schmidt is the President of Schmidt and Libby Health Advisory Group. She is board-certified in infectious diseases and internal medicine, has a master’s degree in Public Health from John Hopkins Bloomberg School of Public Health, and is an associate professor of Clinical Medicine at Virginia Commonwealth University. She practiced her specialty of infectious diseases for 25 years and has many awards and honors including the Best Physicians in America. In addition, Dr. Schmidt has had several leadership positions. She was Chief of Staff at the Inova Fairfax Medical Campus from 2010 through 2013 where she led the quality and citizenship activities of 2,400 physicians. She was a member of the Command Center at Inova Fairfax Hospital for Disaster and Bioterrorism Events and a member of the Inova Health System Oversight Committee for the roll out of the Epic medical record system. Dr. Schmidt has also held the position of Director of Transplant Infectious Diseases for 6 years at Inova Fairfax Hospital where she focused on the medical care of immunocompromised individuals and excellence in the care of transplant patients. Previous Next

  • Thomas S. Dann | Hememics

    Go back Thomas S. Dann Board member Managing Director, Castlehaven Advisors, LLC Mr. Dann has almost 20 years’ experience in technology investing and company building. He was previously Managing Director of two early stage venture funds, the Maryland Venture Fund and ECentury Capital Partners. He also formerly served as a director of Global Internet Ventures, LLC and as Founder and Managing Director of Castlehaven Advisors, LLC. During his venture career, Mr. Dann served as a director of numerous early stage companies, as well as a Director of the Mid-Atlantic Venture Association. He received a B.A. degree from Stanford University and a Juris Doctorate from American University Law School. Previous Next

  • Nha Duong | Hememics

    Go back Nha Duong Board member Investor ​ Previous Next

  • News | Hememics

    Latest News July 20th, 2023 Global Startup Heat Map. Discover 5 Top Point-of-Care (POC) Diagnostics Startups Read More June 8th, 2023 Hememics Biotechnologies, Inc. and General Graphene Corporation Cement Strategic Partnership for Large-Scale Production of Graphene-Based Biosensors Read More June 7th, 2023 TEDCO Invests SSBCI Funding into Hememics Biotechnologies, Inc. Read More June 8th, 2023 Partnership to Mass-Produce Graphene Biosensors Read More June 1st, 2023 Hememics to Showcase Rapid Point of Care Biosensor System at 2023 AACC Expo in Anaheim, CA Read More May 25th, 2023 Hememics Biotechnologies Closes $2M Seed 2 Round Read More July, 2020 U. S. Cities Pilot Connected-Vehicle Tech: Enabling Conventional Vehicles to Communicate Could Save Lives Right Now Read More May 25th, 2023 Hememics Biotechnologies, Inc. Announces Successful Close in $2 Million Seed 2 Financing from TEDCO and Qualified Investors to Accelerate Growth Read More April 21, 2020 Company: New Coronavirus Test Could Diagnose The Virus in 60 Seconds or Less Read More July, 2020 Biosensors for On-The-Spot Tests: Two Companies Plan to Debut New Tech for COVID-19 Testing by Year's End Read More May 30th, 2023 Handheld Multiplexed Biosensor Platform Tests Antibodies, Antigens and Molecular Targets Simultaneously Read More VIEW ALL

  • HemBox | Hememics

    Hem Box TM Impressively Fast & Precise The Hem Box biosensor system is a handheld, field hardened, environmentally resilient analytical device made for rapid on-site identification of bio-hazards present in water, soil, and infected persons. TM HemBox Back < Previous QUOTE ​ The Hem Box can simultaneously identify multiple biological threats and yield sensitive, selective, and measurable data in real time. ​ This data can be stored on the device and transmitted once a Bluetooth device with a secure user account is within range. TM Next >

  • David Ho, PhD | Hememics

    Go back David Ho, PhD Board member & Founder Founder, President & CSO An acknowledged expert on blood platelets who has been at the forefront of blood research for over a decade. Dr. Ho is well-published and has expanded the understanding of how coagulation protein factor XI interacts with platelets. Inventor of an unique desiccation technique to preserve human cells for extended storage. He has been issued three US patents and numerous scientific awards. Has directed numerous inter-organizational projects with academic, government and industry partners for cellular products in wound dressing, tissue regeneration and transfusable applications. Previous Next

  • Hem Station | Hememics

    Hem Station TM Bring Lab Test to The Next Level HemStation Back The HemStation biosensor system is a compact laboratory device able to rapidly and accurately test bio-hazards present in water, soil, and infected persons. ​ The HemStati on used with the Hem Chip ® are able to simultaneously identify multiple biothreats and yield sensitive, selective, and measurable data in real-time. ​ This data can be stored on the device and transmitted once a Bluetooth device with a secure user account is within range. TM TM < Previous

  • Hoa T. Nguyen, PhD | Hememics

    Go back Hoa T. Nguyen, PhD Board member Vice President, AMVI Partners, LLC Director of Phu Sa Trading Co;Ltd Mrs Hoa Nguyen is a professional in significant product development, marketing and sales leadership experience in the agricultural industry sector. She has worked for many years with Monsanto and Syngenta. Hoa also the Director of Phu Sa Vegetable Seed and Agricultural Product Trading Co., LTD. With her experienced as a Former Sales and Marketing Director of East West Seed Vietnam Co. and Former SEA Sales Lead of Vegetable Seed Division, Monsanto USA. Previously, Hoa is the Chief of Representative Office in Vietnam for Seminis Vegetable Seed -USA and Product Development Manager of Vegetable Seed Division, Syngenta Vietnam. Previous Next

  • All News 1 | Hememics

    All News July 20th, 2023 Global Startup Heat Map: Discover 5 Top Point-of-Care (POC) Diagnostics Solutions Startups Read more June 8th, 2023 Hememics Biotechnologies, Inc. and General Graphene Corporation Cement Strategic Partnership for Large-Scale Production of Graphene-Based Biosensors Read more June 8th, 2023 Partnership to Mass-Produce Graphene Biosensors Read more June 7th, 2023 TEDCO Invests SSBCI Funding into Hememics Biotechnologies, Inc. Read more June 1st. 2023 Hememics to Showcase Rapid Point of Care Biosensor System at 2023 AACC Expo in Anaheim, CA Read more May 30th, 2023 Handheld Multiplexed Biosensor Platform Tests Antibodies, Antigens and Molecular Targets Simultaneously Read more May 26th, 2023 Gaithersburg diagnostic company Hememics Biotechnologies nabs millions ahead of larger funding round Read more May 25th. 2023 Hememics Biotechnologies Closes $2M Seed 2 Round Read more Next >

bottom of page